Avaliation of the blood lymphocytes kynetics in bovines after simultaneous application with the synthetics immunogenics anti-Babesia bovis (Sbbo23290) and anti-Ripicephalus (Boophilus) microplus (Bm7462) / Avaliação da cinética leucocitária sangüínea em bovinos após a aplicação simultânea dos imunógenos sintéticos anti-Babesia bovis (SBbo23290) e anti-Ripicephalus (Boophilus) microplus (SBm7462)
AUTOR(ES)
Diogo Coelho de Pádua Oliveira
DATA DE PUBLICAÇÃO
2006
RESUMO
Sixteen bovines belonged to Bos taurus taurus species, serumly and parasitically negatives to hemoparasites, were divided in four groups of inoculation: Control groups, Saponine group, Treatment group I and Treatment group II. The following study had the objective to evaluate and measure the cellular immune response and the protection given to bovines, through simultaneous vaccination of synthetics immunogenics SBbo 23290 in opposite sides (Treatment I) and through vaccination of the same immunogenics SBm 7462 + SB 23290 in the same dose (Treatment II). All animals were inoculated three times, through subcutaneous, with intermissions of thirty days. The challenges were done thirty and thirty-four days after third inoculation, placing 2000 grubs of Ripicephalus Boophilus miroplus, out of hemoparasites, and lately inoculating the strain of Babesia bovis UFV1 ninth passing, in the concentration of 1 x 106 Babesias/ml, respectively. The results show that, along the study, animals vaccinated in two forms related obtained an alteration of the sub population of lymphocytes present in the peripheral blood. Among the population of lymphocytes studied, a bigger increase for the sub population of cells B CD21+ was seen. Through the study of kinetic production of interleukin 4, was valued the activation of blood peripheral mononuclear cells (PBMC) cultivated after vaccination of animals and beforehand stimulated together with synthetic peptides SBbo 23290 e SBm 7462. The quantification of IL-4 production showed low levels for Treatment group I, Treatment group II and Saponine group.
ASSUNTO(S)
ripicephalus (boophilus) microplus medicina veterinaria preventiva resposta imune celular babesia bovis ripicephalus (boophilus) microplus cell immune response babesia bovis
Documentos Relacionados
- Avaliação dos peptídeos sintéticos SBbo23290 e SBm7462 na forma monovalente e polivalente em bovinos desafiados com Riphicephalus (Boophilus) microplus (CANESTRINI, 1887) e Babesia bovis (BABES, 1888; STARCOVICI, 1888)
- Detecção de anticorpos anti-Babesia bovis e anti-Babesia bigemina em bezerros na região de Araguaína, Estado do Tocantins, Brasil
- Estudo in vitro da apoptose induzida em linfócitos de camundongos BALB/c imunizados com o peptídeo sintético anti-carrapato Rhipicephalus (Boophilus) microplus (SBm7462) por via oral e nasal
- Resposta de linfonodos em bovinos inoculados a campo com a vacina recombinante rSBm7462 anti Rhipicephalus (Boophilus) microplus)
- Avaliação in vivo da eficiência de dois imunógenos recombinantes derivados do peptídeo SBm7462 para o controle do carrapato Rhipicephalus (Boophilus) microplus (Canestrini 1887)